New York, NY — The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for the Prevention of Autoimmune Diabetes (GPPAD; “gee-pad”) and its first trial – the Primary Oral Insulin...
index.php edited ak.
